Results 21 to 30 of about 352,140 (294)

Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access (R) GI Monitor assay on the UniCel (R) Dxl 800 Immunoassay System [PDF]

open access: yes, 2008
Background: Gastrointestinal cancer antigen CA19-9 is known as a valuable marker for the management of patients with pancreatic cancer. Methods: The analytical and clinical performance of the Access(R) GI Monitor assay (Beckman Coulter) was evaluated on ...
Barone D   +15 more
core   +3 more sources

Hormone deprivation alters mitochondrial function and lipid profile in the hippocampus [PDF]

open access: yes, 2017
Mitochondrial dysfunction is a common hallmark in aging. In the female, reproductive senescence is characterized by loss of ovarian hormones, many of whose neuroprotective effects converge upon mitochondria.
Alvarez, Silvia   +7 more
core   +2 more sources

The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses [PDF]

open access: yes, 2011
Background: Cancer antigen 125 (CA125) is the best known single tumor marker for ovarian cancer (OC). We investigated whether the additional information of the human epididymis protein 4 (HE4) improves diagnostic accuracy.
Burges, Alexander   +9 more
core   +1 more source

Screening for Gynecologic Conditions With Pelvic Examination US Preventive Services Task Force Recommendation Statement [PDF]

open access: yes, 2017
IMPORTANCE Many conditions that can affect women\u27s health are often evaluated through pelvic examination. Although the pelvic examination is a common part of the physical examination, it is unclear whether performing screening pelvic examinations in ...
Barry, Michael J   +19 more
core   +2 more sources

Sentinel lymph node in early stage ovarian cancer; a literature review [PDF]

open access: yes, 2018
Although sentinel lymph node mapping has been widely implemented in gynecological malignancies in order to minimize the number of unnecessary lymph node dissections and to diminish postoperative morbidity rate, little is known about ovarian cancer ...
Bacalbasa, Nicolae   +4 more
core   +3 more sources

Fertility preservation in gynaecologic cancers [PDF]

open access: yes, 2018
Due to substantial improvement in the diagnosis and treatment of gynaecologic cancers, a better understanding of patient care needs to be revised. We reviewed the literature related to fertility preservation strategies in gynaecological cancer and ...
De Felice, Francesca   +9 more
core   +1 more source

Expression Regulation and Physiological Role of Transcription Factor FOXO3a During Ovarian Follicular Development

open access: yesFrontiers in Physiology, 2020
In mammals, developing ovarian follicles transform from primordial follicles to primary follicles, secondary follicles, and mature follicles, accompanied by changes in follicular secretory functions.
Hong Zhang   +4 more
doaj   +1 more source

Co‐existing monophasic teratoma and uterine adenocarcinoma in a female dog [PDF]

open access: yes, 2019
Ovarian teratomas are occasionally reported in dogs; the rarest type is the monophasic teratoma,composed of tissues originating from only one germ layer. Canine endometrial adenocarcinomas are also rare in dogs and mainly affect geriatric females.
Catarino, J.C   +8 more
core   +2 more sources

CA 125 Elevation: A Descriptive Etiological Study [PDF]

open access: yesNational Journal of Laboratory Medicine, 2016
Introduction: CA 125 (Cancer/Carbohydrate antigen 125) is a surface antigen expressed mostly by the ovarian cancer cells. Hence, it is widely used as a tumour marker for detection and monitoring the progression of such cancers.
Shaheena Appan Parambath   +6 more
doaj   +1 more source

The Role of Three Plasma Proteins in the Diagnosis of Ovarian Tumors [PDF]

open access: yesJournal of Biomedical & Clinical Research, 2022
Ovarian cancer is not common, but it is still the fifth leading cause of death from malignant diseases among women worldwide. More than 200,000 women are diagnosed with ovarian cancer each year globally.
Valeria Racheva   +3 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy